Fletcher CV - Search Results

1

Persistent HIV transcription and variable antiretroviral drug penetration in lymph nodes during plasma viral suppression.

Fletcher CV, Kroon E, Schacker T, Pinyakorn S, Chomont N, Chottanapund S, Prueksakaew P, Benjapornpong K, Buranapraditkun S, Phanuphak N, Ananworanich J, Vasan S, Hsu D; RV254/SEARCH 010 study Group. Fletcher CV, et al. AIDS. 2022 Jun 1;36(7):985-990. doi: 10.1097/QAD.0000000000003201. Epub 2022 Feb 18. AIDS. 2022. PMID: 35184069 Free PMC article.

2

Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons.

Fletcher CV, Kawle SP, Kakuda TN, Anderson PL, Weller D, Bushman LR, Brundage RC, Remmel RP. Fletcher CV, et al. AIDS. 2000 Sep 29;14(14):2137-44. doi: 10.1097/00002030-200009290-00010. AIDS. 2000. PMID: 11061655 Clinical Trial.

3

Indinavir plasma protein binding in HIV-1-infected adults.

Anderson PL, Brundage RC, Bushman L, Kakuda TN, Remmel RP, Fletcher CV. Anderson PL, et al. Among authors: fletcher cv. AIDS. 2000 Oct 20;14(15):2293-7. doi: 10.1097/00002030-200010200-00010. AIDS. 2000. PMID: 11089617

4

Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV- infected subjects: ACTG 884.

Fletcher CV, Acosta EP, Cheng H, Haubrich R, Fischl M, Raasch R, Mills C, Hu XJ, Katzenstein D, Remmel RP, Gulick RM; ACTG Protocol Team. Fletcher CV, et al. AIDS. 2000 Nov 10;14(16):2495-501. doi: 10.1097/00002030-200011100-00011. AIDS. 2000. PMID: 11101060 Clinical Trial.

5

Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavir.

Kakuda TN, Page LM, Anderson PL, Henry K, Schacker TW, Rhame FS, Acosta EP, Brundage RC, Fletcher CV. Kakuda TN, et al. Among authors: fletcher cv. Antimicrob Agents Chemother. 2001 Jan;45(1):236-42. doi: 10.1128/AAC.45.1.236-242.2001. Antimicrob Agents Chemother. 2001. PMID: 11120972 Free PMC article. Clinical Trial.

6

Concentration-controlled compared with conventional antiretroviral therapy for HIV infection.

Fletcher CV, Anderson PL, Kakuda TN, Schacker TW, Henry K, Gross CR, Brundage RC. Fletcher CV, et al. AIDS. 2002 Mar 8;16(4):551-60. doi: 10.1097/00002030-200203080-00006. AIDS. 2002. PMID: 11872998 Clinical Trial.

7

Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals.

Anderson PL, Kakuda TN, Kawle S, Fletcher CV. Anderson PL, et al. Among authors: fletcher cv. AIDS. 2003 Oct 17;17(15):2159-68. doi: 10.1097/00002030-200310170-00003. AIDS. 2003. PMID: 14523272 Clinical Trial.

8

Intrapatient variability of efavirenz concentrations as a predictor of virologic response to antiretroviral therapy.

Brundage RC, Yong FH, Fenton T, Spector SA, Starr SE, Fletcher CV. Brundage RC, et al. Among authors: fletcher cv. Antimicrob Agents Chemother. 2004 Mar;48(3):979-84. doi: 10.1128/AAC.48.3.979-984.2004. Antimicrob Agents Chemother. 2004. PMID: 14982792 Free PMC article. Clinical Trial.

9

Antiretroviral drug-drug interaction considerations for HIV-infected children.

Fletcher CV. Fletcher CV. Pediatr Infect Dis J. 2009 May;28(5):429-30. doi: 10.1097/INF.0b013e3181a622bb. Pediatr Infect Dis J. 2009. PMID: 19395949 Review. No abstract available.

10

Measurement of plasma and intracellular concentrations of raltegravir in patients with HIV infection.

Sandkovsky U, Swindells S, Robbins BL, Nelson SR, Acosta EP, Fletcher CV. Sandkovsky U, et al. Among authors: fletcher cv. AIDS. 2012 Nov 13;26(17):2257-9. doi: 10.1097/QAD.0b013e328359a978. AIDS. 2012. PMID: 22948265

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

228 results

Search Page